harnessing the metabolism of oncogenic signaling for more effective anti-cancer therapy
Published 3 years ago • 122 plays • Length 39:58Download video MP4
Download video MP3
Similar videos
-
44:25
targeted cancer therapy: choosing the right assay to assess parp inhibitors
-
47:59
advances and challenges in targeting kinases in cancer therapeutics
-
28:53
harnessing ht metabolomics and phenotypic profiling for cancer research
-
3:03:33
new strategies for cancer immunotherapy
-
1:09:11
cancer immunotherapy: where will the future opportunities be?
-
1:21:37
penetrating solid tumors with car immune cells
-
2:34
bcma
-
47:41
cancer and biophotonics
-
2:23
the cancer-immunity cycle: crown bioscience's research solutions for preclinical immuno-oncology
-
0:55
breast cancer panel eyes future treatments based on tumor genomic ‘footprint’
-
2:11
molecular subtyping of breast cancer
-
4:59
a novel biomarker for paediatic tumours
-
5:21
innovent biologics - concentrating on cancer cells
-
26:33
pag 2020 series - dr. michael hiller
-
3:49
biome biobank
-
1:06:58
optimization and functional characterization of car t and car nk cells
-
4:59
ts biomarkers, clinical diagnostics, b.r.a.h.m.s - proadm and proavp
-
1:20
(pro)renin receptor: an emerging biomarker and target for fighting cancer